KRAS-targeted cancer vaccine shows promise

Drug Discovery News·Sep 25

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A cancer vaccine targeting KRAS is showing promise in early trials. The vaccine has reportedly shown lasting results and strong responses in patients with pancreatic cancer, and may also be effective against colorectal cancer. Results from the trials suggest the vaccine could be a potential treatment option for these types of cancer.

Full coverage

Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing

Memorial Sloan Kettering Cancer Center·Apr 19

New Targeted Drug Offers Hope in Pancreatic Cancer Treatment | Huntsman Cancer Institute

University of Utah Health·May 7

New KRAS Targeted Therapy Shows Promise Against Pancreatic Cancer

Memorial Sloan Kettering Cancer Center·Apr 21

Pancreatic cancer vaccine shows strong response in early-stage trial

Newsroom | UCLA·Sep 2

Novel vaccine shows promise against KRAS-driven pancreatic and colorectal cancers

News-Medical·Aug 12

Off-The-Shelf Vaccine Elicits Durable Responses in Pancreatic, Colorectal Cancers

Cure Today·Aug 13

Off-the-Shelf Cancer Vaccine Shows Promise in Colorectal and Pancreatic Cancer Patients

Managed Healthcare Executive·Aug 22

Targeting KRAS in Pancreatic Cancer With Biomarkers, Device Therapy

Targeted Oncology·Oct 21

View original report at Drug Discovery News ↗

Fetching the latest headlines…